Anthonie C. Vanekris is Director at Gabelli Healthcare & WellnessRx Trust (GRX). They have made 14 open-market trades across 5 companies since 2007, most recently 2026-02-18.
CIK 0001247238
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $113K since 2007, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GRX | 9,185 | $93K |
| GDV | 2,200 | $62K |
| ECF | 1,000 | $12K |
| BCV | 500 | $11K |
| GCV | 482 | $2K |
| Total | $180K |
Shares reported on the most recent Form 4, priced at the 2026-06-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GGN | SELL | 2026-02-18 | 2026-06-01 | $5.58 | $13K | -5.6% | -6.7% | +9.1% |
| GDV | SELL | 2026-02-18 | 2026-06-02 | $29.15 | $50K | -0.0% | +1.6% | +3.7% |
| GDV | SELL | 2025-10-17 | 2025-12-02 | $26.82 | $25K | +0.1% | +2.5% | +7.1% |
| BCV | SELL | 2025-10-16 | 2026-06-02 | $23.53 | $27K | -5.5% | -6.8% | -10.3% |
| ECF | SELL | 2025-10-16 | 2026-06-02 | $12.26 | $41K | -3.4% | -7.5% | -10.2% |
| GRX | SELL | 2025-08-06 | 2025-12-02 | $9.22 | $83K | -3.2% | -0.8% | +2.6% |
| GRX | SELL | 2025-01-08 | 2025-01-10 | $9.65 | $11K | +5.4% | +6.2% | -3.0% |
| BCV | SELL | 2023-06-12 | 2023-11-07 | $16.98 | $6K | +0.1% | +2.3% | +1.8% |
| ECF | SELL | 2023-03-28 | 2023-11-07 | $7.95 | $5K | -0.3% | +2.1% | +3.4% |
| GDV | SELL | 2022-02-10 | 2022-08-19 | $25.36 | $51K | -5.7% | -8.8% | -6.4% |
| BCV | BUY | 2015-11-09 | 2015-11-10 | $19.40 | $24K | -5.7% | -0.7% | -10.0% |
| ECF | BUY | 2015-11-09 | 2015-11-10 | $8.02 | $24K | -6.1% | -0.6% | -9.7% |
| GRX | BUY | 2013-10-16 | 2014-07-21 | $9.96 | $42K | -6.3% | -0.1% | -0.1% |
| GRX | BUY | 2007-10-25 | 2007-10-25 | $7.70 | $23K | -6.3% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.